Healthcare provider profile · identity verified

Andrea Estes, NP

Nurse Practitioner · ROCHESTER, NY · NPI 1578112298

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	743	279
Amlodipine Besylate	Amlodipine Besylate	425	162
Gabapentin	Gabapentin	326	98
Losartan Potassium	Losartan Potassium	305	114
Albuterol Sulfate Hfa	Albuterol Sulfate	290	101
Omeprazole	Omeprazole	240	82
Metformin Hcl Er	Metformin Hcl	234	96
Lisinopril	Lisinopril	219	80
Famotidine	Famotidine	217	64
Levothyroxine Sodium	Levothyroxine Sodium	204	75
Pantoprazole Sodium	Pantoprazole Sodium	201	60
Hydrochlorothiazide	Hydrochlorothiazide	194	66
Fluticasone Propionate	Fluticasone Propionate	193	74
Duloxetine Hcl	Duloxetine Hcl	188	53
Jardiance	Empagliflozin	168	47
Trazodone Hcl	Trazodone Hcl	146	46
Metoprolol Succinate	Metoprolol Succinate	142	52
Metformin Hcl	Metformin Hcl	109	34
Allopurinol	Allopurinol	101	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	101	29
Spironolactone	Spironolactone	101	28
Sertraline Hcl	Sertraline Hcl	92	19
Eliquis	Apixaban	88	27
Tamsulosin Hcl	Tamsulosin Hcl	88	36
Rosuvastatin Calcium	Rosuvastatin Calcium	86	37
Celecoxib	Celecoxib	85	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	45
Furosemide	Furosemide	83	30
Clopidogrel	Clopidogrel Bisulfate	81	23
Carvedilol	Carvedilol	78	31
Ibuprofen	Ibuprofen	77	31
Prednisone	Prednisone	76	70
Alendronate Sodium	Alendronate Sodium	75	25
Metoprolol Tartrate	Metoprolol Tartrate	73	26
Montelukast Sodium	Montelukast Sodium	73	21
Ozempic	Semaglutide	71	30
Fluoxetine Hcl	Fluoxetine Hcl	67	25
Baclofen	Baclofen	66	23
Ezetimibe	Ezetimibe	63	27
Diclofenac Sodium	Diclofenac Sodium	62	23
Amitriptyline Hcl	Amitriptyline Hcl	60	23
Pregabalin	Pregabalin	60	18
Tizanidine Hcl	Tizanidine Hcl	57	19
Atenolol	Atenolol	56	18
Mirtazapine	Mirtazapine	53	16
Simvastatin	Simvastatin	53	23
Warfarin Sodium	Warfarin Sodium	48	suppressed
Buspirone Hcl	Buspirone Hcl	47	18
Hydroxyzine Hcl	Hydroxyzine Hcl	47	24
Venlafaxine Hcl Er	Venlafaxine Hcl	47	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	15
Farxiga	Dapagliflozin Propanediol	45	17
Quetiapine Fumarate	Quetiapine Fumarate	45	17
Chlorthalidone	Chlorthalidone	44	15
Meclizine Hcl	Meclizine Hcl	44	20
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	43	suppressed
Meloxicam	Meloxicam	43	16
Naproxen	Naproxen	42	13
Lidocaine	Lidocaine	41	15
Hydralazine Hcl	Hydralazine Hcl	40	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Torsemide	Torsemide	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	11
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Nifedipine Er	Nifedipine	37	11
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	34	14
Nitroglycerin	Nitroglycerin	34	19
Topiramate	Topiramate	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Linzess	Linaclotide	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	14
Entresto	Sacubitril/Valsartan	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Bupropion Xl	Bupropion Hcl	29	11
Januvia	Sitagliptin Phosphate	29	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	27
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	14
Escitalopram Oxalate	Escitalopram Oxalate	27	14
Glipizide Er	Glipizide	27	11
Levetiracetam	Levetiracetam	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	18
Ciclopirox	Ciclopirox	25	11
Eplerenone	Eplerenone	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	13
Advair Hfa	Fluticasone Propion/Salmeterol	24	suppressed
Glipizide	Glipizide	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	12
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	12
Ammonium Lactate	Ammonium Lactate	20	suppressed
Dayvigo	Lemborexant	19	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Alprazolam	Alprazolam	17	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	15
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Single Use Swab	Alcohol Antiseptic Pads	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Fluconazole	Fluconazole	14	13
Humalog Kwikpen U-200	Insulin Lispro	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Procto-Med Hc	Hydrocortisone	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Diazepam	Diazepam	12	suppressed
Digoxin	Digoxin	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Wegovy	Semaglutide	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed
Ramipril	Ramipril	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error